Bank Of America Corp Exagen Inc. Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in Exagen Inc. stock. As of the latest transaction made, Bank Of America Corp holds 4,341 shares of XGN stock, worth $26,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,341
Previous 6,089
28.71%
Holding current value
$26,046
Previous $24,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding XGN
# of Institutions
40Shares Held
6.17MCall Options Held
3.4KPut Options Held
18.4K-
Rtw Investments, LP New York, NY1.51MShares$9.07 Million0.09% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$5.35 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$3.19 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.95 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$2.92 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $97.6M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...